Table 1 Clinical characterizations of BRCA1 methylated breast cancer positive cases
From: The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females
Breast Cancer samples (BC) | Age | BRCA 1 status in tumor tissue | ER | PR | HER-2 | Breast cancer tumor type | Histological grade |
|---|---|---|---|---|---|---|---|
13 | 67 | + | +ve | +ve | -ve | ILC | G1 |
138 | 40 | + | +ve | +ve | -ve | IDC | G2 |
172 | 41 | + | +ve | -ve | -ve | IDC | G3 |
154 | 46 | + | +ve | +ve | -ve | IDC | G2 |
176 | 49 | + | -ve | -ve | -ve | IDC | G3 |
116 | 41 | + | -ve | -ve | -ve | metaplastic | Â |
181 | 42 | - | +ve | +ve | -ve | IDC | G2 |
171 | 37 | ND | -ve | -ve | -ve | IDC | G2 |
52 | 69 | - | +ve | +ve | -ve | ILC | G1 |
81 | 27 | - | +ve | -ve | +ve | IDC | G2 |
130 | 39 | + | -ve | -ve | -ve | IDC | G3 |
60 | 40 | + | -ve | -ve | -ve | IDC | G2 |
183 | 36 | + | -ve | -ve | -ve | IDC | G2 |
111 | 44 | ND | +ve | +ve | -ve | IDC | G2 |
161 | 48 | ND | +ve | +ve | -ve | IDC | G2 |
187 | 33 | ND | -ve | -ve | -ve | IDC | G3 |
54 | 40 | - | +ve | +ve | -ve | ILC | Â |
58 | 39 | + | +ve | +ve | -ve | IDC | G2 |
86 | 23 | Â | Â | Â | Â | Fibro adenoma benign | Â |
S3 | 40 | - | +ve | +ve | -ve | ILC | Â |
S2 | 43 | Â | ND | ND | ND | ND | Â |
F2S2 | 39 | Â | ND | ND | ND | ND | Â |